Abdominal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
302
|
18
|
0.100 |
None |
|
0 |
|
|
|
Angina Pectoris
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Sign or Symptom
|
139
|
65
|
0.100 |
None |
|
0 |
|
|
|
Arthralgia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Sign or Symptom
|
248
|
27
|
0.100 |
None |
|
0 |
|
|
|
Dyspnea
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
222
|
26
|
0.100 |
None |
|
0 |
|
|
|
Mitral Valve Insufficiency
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
94
|
11
|
0.100 |
None |
|
0 |
|
|
|
Sudden Cardiac Death
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
133
|
40
|
0.100 |
None |
|
0 |
|
|
|
Ventricular Dysfunction, Left
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
88
|
|
0.100 |
None |
|
0 |
|
|
|
Calcification of the aorta
|
phenotype |
|
Pathologic Function
|
21
|
|
0.100 |
None |
|
0 |
|
|
|
Bleeding tendency
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
71
|
14
|
0.100 |
None |
|
0 |
|
|
|
Precocious atherosclerosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of nervous system physiology
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Pathologic Function
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormal eye physiology
|
phenotype |
|
Pathologic Function
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Malignant neoplasm of gallbladder
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
425
|
81
|
0.030 |
None |
1.000 |
3 |
2
|
2009 |
2019 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
498
|
75
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
1
|
2009 |
2019 |
Biliary Tract Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
167
|
11
|
0.020 |
None |
1.000 |
2 |
1
|
2011 |
2011 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
877
|
43
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Bile duct carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
91
|
10
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
18 |
12
|
2009 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
10 |
12
|
2009 |
2019 |